A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)

NCT01139593 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2015-12-09

No results posted yet for this study

Summary

This is a prospective randomized trial comparing the outcome in women undergoing IVF/ICSI when taking their gonadotropin dosage in the morning (am) or evening (pm).

Conditions

Sponsors & Collaborators

  • Virginia Center for Reproductive Medicine

    lead OTHER

Eligibility

Min Age
21 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2015-11-30
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01139593 on ClinicalTrials.gov